|
|
|
ELNs & Advanced Laboratory Solutions |
 |
|
27-29 September 2010
Marriott Hotel, Amsterdam, The Netherlands
Increase your research efficiency, accelerate workflow and enhance geo-separate collaboration by establishing a clear e-laboratory environment in your company
Building on the resounding success of last year’s event, Europe’s leading forum for data management and ELNs professionals will provide you with a key platform to discuss and find out how others are tackling the main challenges faced in the data management space, as well as the opportunity to network with your peers and forge new contacts in this area.
The expert speaker panel includes:
- Conference Chairman: Seth Pinsky, Director Scientific Informatics and Automation, Abbott Laboratories
- Keynote Presentation: Jim King, Director, R&D Business Technology, Pfizer Diversified Businesses
- Ralph Haffner, Head of Scientific Information Systems, Roche, Germany
- Martin Vanderlaan, Director, Analytical Operations, Genentech
- Dr Jan Hauss, Head of Central Analytics Informatics, Merck
- Edward Reilly, LIMS Administrator, Baxter Healthcare
By attending ELNs & Advanced Laboratory Solutions, you will realise the full potential of your research results and learn how to:
- Avoid project delay or failure by developing best practice, solid approaches when deploying ELN systems
- Create a seamless workflow throughout the lab and between labs by developing an overarching IT architecture to enable data exchange and reporting
- Gain end-user buy-in to increase the project success rate
- Enhance data management and workflow when working with CROs
- Uncover the new trends with ELNs and LIMS: Learn how to leverage the benefits of both systems in our pre-conference focus day
For more information or to register visit www.elnforum.com
|
|
|
|
|
|
 |
|
|
 |
Industry Events |
 |
3rd African Regulatory Conference (ARC)
3-4 May 2012, Accra, Ghana
The African Regulatory Conference offers the opportunity for key stakeholders active on the continent, including representatives from Ministry of Health, local and multinational pharmaceutical companies, to meet to exchange views, discuss topics of interest and identify focus areas for ongoing efforts to increase patient access to new and improved medicines.
More info >> |
|
 |
News and Press Releases |
 |
Norwich Expands Capabilities for Phase I-III Clinical Trials
Norwich Clinical Services (NCS), a global provider of clinical research services for the pharmaceutical and biotech industries, today announced a significant expansion to its clinical research capabilities in order to meet growing market demand. Primary to the expansion, NCS unveiled a new clinical facility with capabilities to conduct all aspects of Phase I – III clinical trials including pharmacokinetics in healthy volunteers, bio-availability and bio-equivalence studies, drug metabolism studies, dose proportionality studies and multiple dose studies.
More info >> |
|
|
